Skip to content

Bacterial Ecology of Pilonidal Cysts

Bacterial Ecology of Pilonidal Cysts

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05513885
Acronym
PILOBAC
Enrollment
100
Registered
2022-08-24
Start date
2024-06-24
Completion date
2025-01-31
Last updated
2024-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Cysts

Brief summary

Bacterial ecology of pilonidal cysts Single centre retrospective exploratory study of medical data contained in the medical records of patients operated on in the centre between 01/08/2020 and 30/11/2020.

Detailed description

From the medical records of a series of patients treated for pilonidal cysts: 1. Describe the bacteriological analyses performed on a series of non-abscessed pilonidal cysts before laser treatment 2. Compare the bacterial flora of cysts operated on in the first instance and those reoperated on This is a retrospective monocentric study of medical data contained in the medical records of patients operated on for pilonidal cysts and who received the same protocol: * Antibiotic prophylaxis (injection of 2g of Augmentin) * Treatment of the cyst by laser, under general anaesthesia, after dilatation of the pilonidal sinus, evisceration and bacteriological swabbing. * Post-operative monitoring and local care

Interventions

None listed

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient aged 18 years or older, * Patient who has been informed about the research; * Patient with a pilonidal cyst treated with Holmium Laser during a scheduled procedure.

Exclusion criteria

* Patient under legal protection, guardianship or curatorship; * Patient who has indicated his opposition to the use of his data; * Patient undergoing emergency surgery for an abscess.

Design outcomes

Primary

MeasureTime frameDescription
Main germs incidence rateDay 1Calculation of the the incidence rates of the main germs

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026